United States · Investor

Arcus Ventures

Last cheque observed Aug 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietNew fund $36M, Apr 2014VC firm

Series BSeries ASeries CAdvanced MaterialsTherapeutics

Cheques on record
0%of best year0cheques in 12 months, 14 on record
Since the last cheque2638days00hrs00min00sec
Median round$25MRounds led0 of 14Mostly inUnited States, 100%
Pitch Arcus Ventures

Arcus Ventures highlights

  1. 01

    14 rounds on record

  2. 02

    Mostly Series B and Series A: 64% of its rounds

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
Advanced MaterialsTherapeutics
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first14 appearances

  1. 2019

    1 round

  2. Aug
    Cleave TherapeuticsSeries C · US · Businesswire$12MWith 8 others
  3. 2016

    1 round

  4. Aug
    Cleave BioscienceSeries B · US · FinSMEs$37MWith 2 others
  5. 2015

    2 rounds

  6. Sept
    Exosome DiagnosticsSeries B · US$18MWith 4 others
  7. Jun
    XTuit PharmaceuticalsSeries A · US$22MWith 4 others
  8. 2014

    3 rounds

  9. Sept
    TRACON PharmaceuticalsSeries B · US$27MWith 5 others
  10. Jul
    Epic SciencesSeries C · US$30MWith 4 others
  11. Mar
    Exosome DiagnosticsSeries B · US$27MWith 4 others
  12. 2013

    1 round

  13. Mar
    T2 BiosystemsSeries E · US · pevc.dowjones.com$40MWith 9 others
  14. 2012

    1 round

  15. Mar
    Molecular ImagingSeries A · US · molecularimaging.com$9.9MWith 3 others
  16. 2011

    3 rounds

  17. Aug
    T2 BiosystemsSeries D · US · masshightech.com$23MWith 9 others
  18. May
    Molecular ImagingSeries A · US · finsmes.com$7.0MWith 1 other
  19. Apr
    TRACON PharmaceuticalsSeries A · US · traconpharma.com$14MWith 1 other
  20. 2010

    2 rounds

  21. Nov
    Vascular PathwaysSeries B · US · finsmes.com$14MWith 3 others
  22. May
    T2 BiosystemsSeries C · US · onbiovc.com$15MWith 8 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration2 named

JBJames B. DoughertyManaging Member of the General PartneriFiling they signed
SLSteven L. SoignetManaging Member of the General PartneriFiling they signed

We also hold 5 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Who they invest alongside

The investors most often in the same rounds as Arcus Ventures. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Arcus Ventures put money into.

Quick answers about Arcus Ventures

What does Arcus Ventures invest in?

Arcus Ventures invests most often at Series B and Series A (64% of the rounds on record), in sectors such as Advanced Materials and Therapeutics.

How active is Arcus Ventures?

14 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2019.

What has Arcus Ventures invested in recently?

Its most recent investments on record: Cleave Therapeutics (Series C, Aug 2019) and Cleave Bioscience (Series B, Aug 2016).

How big are Arcus Ventures's cheques?

The median round it joins is $25M.

Does Arcus Ventures lead rounds?

Rarely, if at all: none of its 14 investments on record names it as the lead.

Where does Arcus Ventures invest?

Most of the companies it backs are in the United States (100%).

Is Arcus Ventures investing now?

No investments in the last 12 months; the latest was in Aug 2019.

Who does Arcus Ventures invest alongside?

Most often Polaris Partners (4 rounds together), Camros Capital (3 rounds together) and Flagship Pioneering, LLC (3 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it